8E

Cytek Biosciences IncMUN Cytek Stock Report

Last reporting period 30 Jun, 2024

Updated —

Last price

Market cap $B

0.685

Micro

Exchange

XMUN - Boerse Muenchen

8EQ.MU Stock Analysis

8E

Uncovered

Cytek Biosciences Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

32/100

Low score

Market cap $B

0.685

Dividend yield

Shares outstanding

135.43 B

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company offers cell analysis tools by leveraging technical approaches. Its instruments, the Aurora and Northern Lights systems, are the spectrum flow cytometers able to deliver cell analysis by utilizing the spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells (Full Spectrum Profiling (FSP)). The Company’s FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize a method of light detection and distribution. The Company's FSP platform includes its instruments, the Aurora and Northern Lights systems; its cell sorter, the Aurora cell sorter (CS), and reagents, software and services to provide an integrated suite of solutions for its customers.

View Section: Eyestock Rating